Abiopharma

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

So-Young to Report Second Quarter 2025 Financial Results on August 15, 2025

FDA approve EXEMESTANE

FDA approve EXEMESTANE

FDA approve DEXTROSE

FDA approve CEVIMELINE HYDROCHLORIDE

FDA approve FAMOTIDINE

FDA approve CEFPROZIL

FDA approve EXEMESTANE

FDA approve PHENTERMINE HYDROCHLORIDE

FDA approve NAPROXEN SODIUM

Pink Limited symbol attribute type Security_Name was changed. Previous value: BEIGENE LTD. New value: BEONE MEDICINES LTD.

Ikena Oncology (IKNA) was removed from the list of traded instruments on NASDAQ exchange